Despite the much improvement in treatment for ALL, childhood ALL with MLL-rearrangement (MLL-r) still displays inferior prognosis attributed to hyperleukocytosis, aggressive form with early relapse, and central nervous system involvement (4–6), distinguishing itself from other leukemia subgroups. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.